✨ Your Portfolio is fetched and updated from zerodha.
Small Pharmaceuticals

Alembic Pharmaceuticals Ltd.

APLLTD

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹18,116 Cr.
P/E
28.56

Alembic Pharmaceuticals Ltd.

  • Alembic Pharma
  • Jubilant Pharmova
  • Caplin Point Lab
  • TJI Pharma

FAQs on Alembic Pharmaceuticals Ltd. Shareprice

Alembic Pharma has given lower returns compared to its competitors.
Alembic Pharma has grown at ~7.54% over the last 8yrs while peers have grown at a median rate of 13.46%

Alembic Pharma is not expensive.
Latest PE of Alembic Pharma is 28.56, while 3 year average PE is 29.77.
Also latest EV/EBITDA of Alembic Pharma is 17.17 while 3yr average is 18.57.

View FAQ's On Business

Growth Table

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Caplin Point Lab

Balance Sheet

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Caplin Point Lab

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Caplin Point Lab

Cash Flow

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Caplin Point Lab

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Caplin Point Lab

Quarterly Results

  • Alembic Pharmaceuticals Ltd.
  • Jubilant Pharmova
  • Caplin Point Lab

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Alembic Pharmaceuticals Ltd. Financials

Balance sheet of Alembic Pharma is strong.
But short term working capital might become an issue for this company.

Yes, The net debt of Alembic Pharma is increasing.
Latest net debt of Alembic Pharma is ₹1,271 Crs as of Sep-25.
This is greater than Mar-25 when it was ₹1,016 Crs.

The profit is oscillating.
The profit of Alembic Pharma is ₹631 Crs for TTM, ₹583 Crs for Mar 2025 and ₹616 Crs for Mar 2024.

The company seems to pay a good stable dividend.
Alembic Pharma latest dividend payout ratio is 37.06% and 3yr average dividend payout ratio is 39.38%

Companies resources are allocated to majorly unproductive assets like Inventory

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech